Services-Medical Laboratories · DE · CIK 1447362
Offers molecular diagnostic tests to aid clinicians in diagnosing and treating dermatologic cancers, Barrett's esophagus, atopic dermatitis, and uveal melanoma
Comparable business profile · signals at a glance
In the 90 days to Mar 26, 2026: 4 sold $4.1M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 26, 2026 | Maetzold Derek JPres. & Chief Exec. Officer | Sell | 1,357 | $25.55 | $35K |
| Mar 26, 2026 | Maetzold Derek JPres. & Chief Exec. Officer | Sell | 1,153 | $25.55 | $29K |
| Mar 26, 2026 | Maetzold Derek JPres. & Chief Exec. Officer | Sell | 550 | $25.55 | $14K |
| Mar 26, 2026 | Maetzold Derek JPres. & Chief Exec. Officer | Sell | 278 | $25.55 | $7K |
| Mar 18, 2026 | Maetzold Derek JPres. & Chief Exec. Officer | Sell | 650 | $25.39 | $17K |
| Mar 17, 2026 | Maetzold Derek JPres. & Chief Exec. Officer | Sell | 18,650 | $25.93 | $484K |
| Mar 16, 2026 | Maetzold Derek JPres. & Chief Exec. Officer | Sell | 17,449 | $25.96 | $453K |
| Mar 16, 2026 | Maetzold Derek JPres. & Chief Exec. Officer | Sell | 126 | $26.68 | $3K |
| Mar 13, 2026 | Maetzold Derek JPres. & Chief Exec. Officer | Sell | 13,204 | $25.45 | $336K |
| Mar 12, 2026 | Maetzold Derek JPres. & Chief Exec. Officer | Sell | 23,179 | $25.28 | $586K |
| Mar 12, 2026 | Juvenal Tobin WChief Commercial Officer | Sell | 20,863 | $25.24 | $527K |
| Mar 11, 2026 | Maetzold Derek JPres. & Chief Exec. Officer | Sell | 17,310 | $26.11 | $452K |
| Mar 11, 2026 | Maetzold Derek JPres. & Chief Exec. Officer | Sell | 1,357 | $26.11 | $35K |
| Mar 11, 2026 | Maetzold Derek JPres. & Chief Exec. Officer | Sell | 1,160 | $26.11 | $30K |
| Mar 11, 2026 | Maetzold Derek JPres. & Chief Exec. Officer | Sell | 282 | $26.11 | $7K |
| Mar 11, 2026 | Maetzold Derek JPres. & Chief Exec. Officer | Sell | 279 | $26.11 | $7K |
| Mar 5, 2026 | Stokes FrankChief Financial Officer | Sell | 6,001 | $27.98 | $168K |
| Mar 5, 2026 | Cole G BradleyDirector | Sell | 4,748 | $28.44 | $135K |
| Mar 5, 2026 | Cole G BradleyDirector | Sell | 2,655 | $28.51 | $76K |
| Mar 3, 2026 | Stokes FrankChief Financial Officer | Sell | 5,300 | $27.32 | $145K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.